124 related articles for article (PubMed ID: 6688611)
21. Avascular necrosis of the femoral head with combination therapy.
Sweet DL; Roth DG; Desser RK; Miller JB; Ultmann JE
Ann Intern Med; 1976 Jul; 85(1):67-8. PubMed ID: 937924
[TBL] [Abstract][Full Text] [Related]
22. Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.
Farney RJ; Morris AH; Armstrong JD; Hammer S
Am Rev Respir Dis; 1977 Jan; 115(1):135-45. PubMed ID: 835882
[TBL] [Abstract][Full Text] [Related]
23. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
24. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
Ekert H
Cancer Treat Res; 1989; 41():241-6. PubMed ID: 2484293
[No Abstract] [Full Text] [Related]
25. Osteonecrosis in patients with Hodgkin disease following combination chemotherapy.
Albala MM; Steinfeld AD; Khilnani MT
Med Pediatr Oncol; 1980; 8(2):165-70. PubMed ID: 7421733
[TBL] [Abstract][Full Text] [Related]
26. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Andrieu JM; Colonna P
J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
[No Abstract] [Full Text] [Related]
27. Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study.
Jones SE; Haut A; Weick JK; Wilson HE; Grozea P; Fabian CJ; McKelvey E; Byrne GE; Hartsock R; Dixon DO; Coltman CA
Cancer; 1983 Apr; 51(8):1339-47. PubMed ID: 6186355
[No Abstract] [Full Text] [Related]
28. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.
Ekert H; Waters KD; Smith PJ; Toogood I; Mauger D
J Clin Oncol; 1988 Dec; 6(12):1845-50. PubMed ID: 3058876
[TBL] [Abstract][Full Text] [Related]
29. Gallium citrate Ga 67 accumulation in pulmonary lesions after chemotherapy (MOPP).
Wells JD; Huskison WT; Davenport OL
South Med J; 1986 Oct; 79(10):1293-6. PubMed ID: 3464101
[TBL] [Abstract][Full Text] [Related]
30. Acute nonlymphocytic leukemia after radiation and MOPP chemotherapy for Hodgkin's disease.
Lavey RS
J Clin Oncol; 1990 Dec; 8(12):2089-90. PubMed ID: 2230901
[No Abstract] [Full Text] [Related]
31. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
32. [Acute myeloid leukemia after treatment of Hodgkin's disease].
Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
[TBL] [Abstract][Full Text] [Related]
33. [10 years of DeVita protocol].
Gassmann W; Schmitz N; Löffler H
Dtsch Med Wochenschr; 1982 Jul; 107(27):1043-4. PubMed ID: 6896303
[No Abstract] [Full Text] [Related]
34. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
35. Hodgkin's disease, splenectomy and secondary leukemia.
Centurioni R; Brianzoni F; Leoni P; Danieli G
Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
[No Abstract] [Full Text] [Related]
36. Multiple-drug therapy in Hodgkin's disease.
Rubens RD; Wiltshaw E; Boesen E; Galton DA
Eur J Cancer (1965); 1972 Oct; 8(5):477-84. PubMed ID: 4651783
[No Abstract] [Full Text] [Related]
37. Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
da Cunha MF; Meistrich ML; Fuller LM; Cundiff JH; Hagemeister FB; Velasquez WS; McLaughlin P; Riggs SA; Cabanillas FF; Salvador PG
J Clin Oncol; 1984 Jun; 2(6):571-7. PubMed ID: 6547167
[TBL] [Abstract][Full Text] [Related]
38. Twenty years of MOPP therapy for Hodgkin's disease.
Longo DL; Young RC; Wesley M; Hubbard SM; Duffey PL; Jaffe ES; DeVita VT
J Clin Oncol; 1986 Sep; 4(9):1295-306. PubMed ID: 3528400
[TBL] [Abstract][Full Text] [Related]
39. Osteonecrosis of the jaws: a complication of cancer chemotherapy.
Schwartz HC
Head Neck Surg; 1982; 4(3):251-3. PubMed ID: 6896046
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy-induced non-Hodgkin's lymphoma in a patient with Hodgkin's disease--a case report.
Burney IA; Malik IA
J Pak Med Assoc; 1996 Jan; 46(1):14-5. PubMed ID: 8830160
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]